Erwin Schoof - Research
Erwin Schoof, PhD student
|
|
---|---|
![]() Using a wide variety of experimental and computational techniques, we are attempting to elucidate signaling network dynamics associated with cancer metastasis in several cancer types. Through the integration of different types of data (e.g. proteomics, genomics and imaging), we aim to gain a more complete understanding of underlying cellular processes which can be targeted therapeutically. |
|
|
|
|
---|---|
![]() With current updated versions of our flagship algorithms NetPhorest and NetworKIN, we are modeling large-scale (phospho-) proteomics datasets in order to determine differential kinase and phosphatase activity profiles in different diseases, cell-lines and experimental conditions. These results can be used for diagnostic and/or therapeutic purposes. Through large-scale in vitro screening, we are deciphering novel kinase specificities in an attempt to obtain a kinome-wide modeling framework. |
|
|
|
|
---|---|
![]() Mass Spectrometry is the method of choice when wanting to analyze global protein dynamics within a cell. We are deploying state-of-the-art instruments to get as in-depth a proteome coverage as possible, while allowing the utilization of quantitationtechniques such as SILAC or dimethyl labeling. Using fractionation techniques such as SCX, SAX and HILIC, combined with enrichment strategies such as Titanium Dioxide (TiO2) and immuno-precipitation (IP), we are constantly trying to push the envelope of gaining greater (phospho-) proteome coverage which allows for more accurate modeling of cell behaviour. |
|
|
|
|
---|---|
|
![]() The dynamics of signaling networks within a cell alter not only through longer periods of time, but has also been attributed to disease progression. Mutations occurring at the DNA level affect protein sequences at the proteome level, which in turn can significantly alter the cellular phenotype. Through computational studies, we have elucidated evolutionary patterns underlying these phenomena, and are attempting to deploy these in the study of human diseases. |
|